Zydus’ Third Quarter Results Met With Mixed Analyst Reactions

As Firm Strikes Fresh Deal With Synthon For 505(b)(2) Product

 
• By Adam Zamecnik
  
Zydus lifesciences building, India
Zydus Lifesciences has announced new North American leadership • Source: Shutterstock

More from Earnings

More from Generics Bulletin